What does the evidence say about Vitamin D Bone Strength Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Vitamin D Bone Strength Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - The first group includes supplements supported by a robust theoretical foundation and extensive empirical evidence confirming their efficacy and safety. [Soltani Mohammad (2026); evidence level 1] - The second group comprises supplements with a plausible scientific rationale but inconsistent evidence regarding their effectiveness, necessitating further research. [Soltani Mohammad (2026); evidence level 1] - Its anti‐inflammatory properties and role in reducing fracture risk, muscle weakness, and tendinopathy are well‐documented [,]. [Soltani Mohammad (2026); evidence level 1] - 1 2 3 1 4 5 6 7 8 9 10 11 Dietary supplements, defined as nutrients or compounds ingested to enhance health or performance beyond habitual diets [], are widely used by athletes and the general population [,]. [Soltani Mohammad (2026); evidence level 1] - Specifically, 48.0% (12/25) of participants in the alfacalcidol group and 12.0% (3/25) in the control group achieved improvement in muscle mass or function, yielding an absolute difference of 36.0% (95% CI 12.6% – 59.4%; P = 0.005), with a relative risk (RR) of 1.69 (95% CI 1.13–2.53). [Wang L (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.